"The OBBA includes broad and sweeping changes that will have a profound impact," writes Allan Shen, CFP.
Allan Shen, CFP
Advertisement
Shen is a financial and investment strategy associate at MEDIQUS Asset Advisors, Inc.
Articles by Allan Shen, CFP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
EV plus pembro approval reframes first conversation in MIBC diagnosis
3
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
4
Ravi Munver, MD, highlights study of first- and second-generation Aquablation systems
5